Literature DB >> 20560968

Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes.

Elizabeth M Tegg1, Russell J Thomson, Jim Stankovich, Annette Banks, Ceri Flowers, Rebekah McWhirter, Jean Panton, Anne Piaszczyk, Melanie Bahlo, Katherine A Marsden, Ray M Lowenthal, Simon J Foote, Joanne L Dickinson.   

Abstract

A family history of a haematological malignancy (HM) is known to be a risk factor for HMs. However, collections of large families with multiple cases of varied disease types are relatively rare. We describe a collection of 12 families with dense aggregations of multiple HM subtypes. Cases were ascertained from a population based study conducted between 1972 and 1980 in Tasmania, Australia. Diagnoses were confirmed through review and re-examination of stored tissue, pathology reports, Tasmanian Cancer Registry and flow cytometry records. Family trees were generated and kinship coefficients were calculated for all pairs of affected individuals. 120 cases were found in these families. Cases diagnosed with chronic lymphocytic leukaemia (CLL) demonstrated the most significantly increased aggregation (P < 0.0001). There was also significant evidence that those individuals diagnosed at an older age (>53 years), did not aggregate together in families with disease that presented at an earlier age (<20 years) (P = 0.009).

Entities:  

Mesh:

Year:  2010        PMID: 20560968     DOI: 10.1111/j.1365-2141.2010.08267.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Evaluating a CLL susceptibility variant in ITGB2 in families with multiple subtypes of hematological malignancies.

Authors:  Nicholas B Blackburn; James R Marthick; Annette Banks; Jac C Charlesworth; Katherine A Marsden; Ray M Lowenthal; John Blangero; Joanne L Dickinson
Journal:  Blood       Date:  2017-05-10       Impact factor: 22.113

2.  A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study.

Authors:  Nicholas B Blackburn; Jac C Charlesworth; James R Marthick; Elizabeth M Tegg; Katherine A Marsden; Velandai Srikanth; John Blangero; Ray M Lowenthal; Simon J Foote; Joanne L Dickinson
Journal:  Oncol Rep       Date:  2014-10-24       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.